Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 Study of SSS07 in Healthy Subjects
NCT02460393Phase 1Completed
- Sponsor
- 3SBio
- Start
- May 2015
- Primary completion
- Nov 2015
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in rheumatoid arthritis (RA) comparing SSS07 (5-100 mg) with Placebo (2 arms). Primary endpoints: Area Under the Curve at 28 days, Maximum Plasma Concentration at 28 days and 2 more. Started May 2015; status: completed.
02
Drugs
SSS07
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02460393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02460393.